Insights & Education

Articles

Looking Ahead to 2026: Setting New Standards in Pharmacy Benefits Management

Plan sponsors deserve complete visibility into pharmacy spend. Learn how fiduciary commitment and Full Disclosure are reshaping PBM partnerships in 2026.

By Ken Kemker • January 4, 2026 • 2 min read

Looking Ahead to 2026: Setting New Standards in Pharmacy Benefits Management

In 2026, pharmacy benefits will require greater accountability from PBM partners. Plan sponsors are increasingly seeking complete visibility into their pharmacy spend and requesting partners who serve their interests first.

At DisclosedRx, we’re proud to lead this transformation as The Fiduciary and Fully Disclosed PBM®, setting the standard for what plan sponsors should expect from their pharmacy benefits management relationship.

The Growing Demand for Full Disclosure

The traditional PBM model, often clouded by complex pricing structures and obscured revenue streams, is rapidly becoming obsolete. Forward-thinking organizations are recognizing that Full Disclosure isn’t just a phrase; it’s a fundamental requirement for effective cost management and optimal member care.

As The Fiduciary and Fully Disclosed PBM®, we’re seeing more plan sponsors embrace our model, which includes:

  • 100% pass-through of all drug pricing
  • 100% pass-through of all rebates
  • A single, clearly defined administrative fee
  • Complete visibility into every aspect of drug spend

Why 2026 Will Be Different

The coming year represents a pivotal moment in pharmacy benefits management. Our Enhanced Specialty Cost Control programs demonstrate how Full Disclosure drives real results, delivering as much as 75% savings per fill while reducing member copays, often to zero. This approach proves that plan sponsors can provide exceptional benefits while maintaining cost control through genuine partnership with their PBM.

The Path Forward

Ask your current or prospective PBM these essential questions:

  • Do they act as a fiduciary, contractually bound to act in your best interests?
  • Do they contractually guarantee 100% pass-through of all drug pricing?
  • Are 100% of rebates passed through to your plan?
  • Can they clearly explain all revenue sources?

Conclusion

As we move into 2026, the choice is clear: continue with traditional PBM practices or embrace fiduciary partnership and Full Disclosure. At DisclosedRx, we’re proud to lead this transformation, proving that when you combine fiduciary commitment and Full Disclosure with innovation and exceptional service, you create a model that truly serves the best interests of plans and their members.

https://disclosedrx.com/

Keep reading.

More short reads on how pharmacy benefits actually work.

All articles ›

Articles

What is a Member-First PBM?

What does member-first really mean for a PBM? How DisclosedRx's pay model, Savings Program and Member Advocates show…

September 15, 2026 • 5 min read

Get the next one when it publishes.

One email a month. Nothing else, and no sales calls.

Have a question we haven't written about yet?

Ask us. A person answers, and if the answer is worth publishing we will write it up.

Or call us direct: 888-589-3340